.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Moodys
Novartis
Colorcon
Farmers Insurance
Cantor Fitzgerald
US Army
Julphar
Argus Health
Merck

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020606

« Back to Dashboard

NDA 020606 describes IMODIUM MULTI-SYMPTOM RELIEF, which is a drug marketed by J And J Consumer Inc and is included in two NDAs. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the IMODIUM MULTI-SYMPTOM RELIEF profile page.

The generic ingredient in IMODIUM MULTI-SYMPTOM RELIEF is loperamide hydrochloride; simethicone. There are eleven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the loperamide hydrochloride; simethicone profile page.

Summary for 020606

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, CHEWABLE;ORALStrength2MG;125MG
Approval Date:Jun 26, 1996TE:RLD:Yes

Expired Orange Book Patents for NDA: 020606

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer IncIMODIUM MULTI-SYMPTOM RELIEFloperamide hydrochloride; simethiconeTABLET, CHEWABLE;ORAL020606-001Jun 26, 1996► Subscribe► Subscribe
J And J Consumer IncIMODIUM MULTI-SYMPTOM RELIEFloperamide hydrochloride; simethiconeTABLET, CHEWABLE;ORAL020606-001Jun 26, 1996► Subscribe► Subscribe
J And J Consumer IncIMODIUM MULTI-SYMPTOM RELIEFloperamide hydrochloride; simethiconeTABLET, CHEWABLE;ORAL020606-001Jun 26, 1996► Subscribe► Subscribe
J And J Consumer IncIMODIUM MULTI-SYMPTOM RELIEFloperamide hydrochloride; simethiconeTABLET, CHEWABLE;ORAL020606-001Jun 26, 1996► Subscribe► Subscribe
J And J Consumer IncIMODIUM MULTI-SYMPTOM RELIEFloperamide hydrochloride; simethiconeTABLET, CHEWABLE;ORAL020606-001Jun 26, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
US Army
Julphar
Queensland Health
Chinese Patent Office
Mallinckrodt
Farmers Insurance
Deloitte
Harvard Business School
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot